1. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer
    Jia-Qi Wu et al, 2017, J Exp Clin Cancer Res CrossRef
  2. Roles of neutrophils in cancer growth and progression
    Maria Rosaria Galdiero et al, 2017, J Leukoc Biol CrossRef
  3. Alpha, 2’-dihydroxy-4,4’-dimethoxydihydrochalcone inhibits cell proliferation, invasion, and migration in gastric cancer in part via autophagy
    Boshun Wan et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  4. CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma
    Xiang Chen et al, 2018, Urologic Oncology: Seminars and Original Investigations CrossRef
  5. Cancer Inflammation and Cytokines
    Maria Rosaria Galdiero et al, 2018, Cold Spring Harb Perspect Biol CrossRef
  6. A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma
    Qi Zhong et al, 2018, Sci Rep CrossRef
  7. Killing the muscular larvae of Trichinella spiralis and the anti-fibrotic effect of the combination of Wortmannilatone F and recombinant G31P in a murine model of trichinellosis
    Yixin Ren et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  8. Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
    Valeria Mollica Poeta et al, 2019, Front. Immunol. CrossRef
  9. Cancer-associated Fibroblasts-derived IL-8 Mediates Resistance to Cisplatin in Human Gastric Cancer
    Jing Zhai et al, 2019, Cancer Letters CrossRef
  10. EGFR and CXCR1 expression in thyroid carcinoma in Qassim Region-Saudi Arabia: Correlation with Clinicopathological Parameters
    Ola M. Omran, 2019, Pathophysiology CrossRef
  11. null
    M. Blanca Piazuelo et al, 2019 CrossRef
  12. null
    R.A. Lacalle et al, 2017 CrossRef
  13. Targeting CXCR1/2: The medicinal potential as cancer immunotherapy agents, antagonists research highlights and challenges ahead
    Jinxin Che et al, 2019, European Journal of Medicinal Chemistry CrossRef
  14. Comparing the Molecular Biological Characteristics between Gastric Cancer and Atrial Fibrillation Based on mRNA Expression Profiles
    伟 曾, 2020, HJCB CrossRef
  15. Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme
    Vasiliki Koliaraki et al, 2020 CrossRef
  16. Athymic Nude Mice as an Experimental Model for Cancer Treatment
    I. SZADVARI et al, 2016, Physiol Res CrossRef
  17. Multiple anti-tumor effects of Reparixin on thyroid cancer
    Federica Liotti et al, 2017, Oncotarget CrossRef
  18. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
    Yanbin Wang et al, 2021, Int J Cancer CrossRef
  19. Molecular Mechanism of Resistance to Chemotherapy in Gastric Cancers, the Role of Autophagy
    Liudmila V. Spirina et al, 2020, CDT CrossRef
  20. null
    Yang Xun et al, 2020 CrossRef
  21. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment
    Julia López de Andrés et al, 2020, J Hematol Oncol CrossRef
  22. The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases
    Shahid Hussain et al, 2020, Front. Immunol. CrossRef
  23. Immune determinants of Barrett’s progression to esophageal adenocarcinoma
    Kiran H. Lagisetty et al, 2021 CrossRef
  24. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
    Jan Korbecki et al, 2021, IJMS CrossRef
  25. Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils
    S. Narla et al, 2021, Br J Dermatol CrossRef
  26. Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
    Yuan Cheng et al, 2021, Mol Cancer CrossRef
  27. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
    Sugandha Saxena et al, 2021, Cancer Metastasis Rev CrossRef
  28. null
    Niradiz Reyes et al, 2021 CrossRef
  29. Chemokine Receptor Antagonists: Role in Oncology
    Sean Kraus et al, 2021, Curr Oncol Rep CrossRef
  30. Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis
    Tania Ray et al, 2021, Front. Oncol. CrossRef
  31. Design, synthesis and anti-tumor evaluation of 1,2,4-triazol-3-one derivatives and pyridazinone derivatives as novel CXCR2 antagonists
    Xun Zhang et al, 2021, European Journal of Medicinal Chemistry CrossRef
  32. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy
    Pedro Bule et al, 2021, IJMS CrossRef
  33. Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms
    Jan Korbecki et al, 2021, IJMS CrossRef
  34. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
    Kai Li et al, 2021, Sig Transduct Target Ther CrossRef
  35. Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?
    Nathan Karin, 2021, Cancers CrossRef
  36. Multifaceted role of chemokines in solid tumors: from biology to therapy
    Sana Raza et al, 2022, Seminars in Cancer Biology CrossRef
  37. CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space
    Jan Korbecki et al, 2022, IJMS CrossRef
  38. Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers
    Shweta Arora et al, 2022, Seminars in Cancer Biology CrossRef
  39. Targeting IL8 as a sequential therapy strategy to overcome chemotherapy resistance in advanced gastric cancer
    Huning Jiang et al, 2022, Cell Death Discov. CrossRef